amino acid homology, each recombinant form can induce the same broad spectrum of responses, including fever (19) .
During the early investigation into the pathogenesis of fever, there was speculation that another leukocyte product, interferon, also caused fever. From the first clinical trials using partially purified IFNs, fever had become the major side effect of IFN therapy (20) . Current clinical trials using recombinant forms have confirmed the observations that IFNs, particularly IFN-o~, cause fever. Recently (21, 22) it was shown that IFN-a produces fever not because it is contaminated with endotoxins or induces IL-1, but rather because IFN-a is intrinsically pyrogenic by its direct action on the thermoregulatory center (21, 22) . Thus, from a conceptual point of view, a second molecule exists with endogenous pyrogen activity, rIFN-a meets the criteria for being an endogenous pyrogen: it produces a brisk, monophasic fever following intravenous injection into rabbits and mice, is free of endotoxins, and increases the production of PGE2 from brain tissue in vitro and in vivo.
We now report that another leukocyte product, tumor necrosis factor (TNF; cachectin) (23) , is also intrinsically pyrogenic. Recombinant human tumor necrosis factor (rTNF00 produces a brisk, monophasic fever after intravenous injection into rabbits, and the fever is not due to contaminating endotoxin. However, unlike IFN-a, rTNF0~ also induces IL-1 in vivo and in vitro. These results, along with those observed with IFN-a and IL-1, support an expanded hypothesis for the pathogenesis of fever involving several endogenous pyrogens.
Materials and Methods
Materials. Human rTNFc~ was expressed in Escherichia coli and purified to homogeneity (24) . Limulus amebocyte lysate (LAL) (Mallinckrodt, Inc., St. Louis, MO) testing employed an E. coil standard (Mallinckrodt, Inc.) and detected 10 pg/ml (0.1 endotoxin unit). Various lots of rTNFc~ were tested and revealed 200 pg or less of endotoxin per milligram of rTNFa. Adding rTNF~ to known quantities of endotoxin did not interfere with the LAL assay. Using gas chromatography/mass spectrometry (5840A and 5985B, respectively, Hewlett-Packard Co., Palo Alto, CA), /3-hydroxymyristic acid in rTNFc~ preparations was not detected above background levels (sterile water was <40 pg/mg). Adding known amounts of endotoxin to rTNFc~ resulted in complete recovery of the calculated amount of ~-hydroxymyristic acid (25) . The human rIL-1 used in these studies was the pI 7 form (16), provided by Cistron Technology, Inc. (Pine Brook, NJ). rIL-1 was expressed in E. coil and consisted of amino acids 112-269 of the precursor sequence. LAL testing used lysate from Associates of Cape Cod (Woods Hole, MA) with a sensitivity of 20 pg/ml (0.2 endotoxin unit) using the E. coli standard EC-5 (Bureau of Biologics, Bethesda, MD). The rIL-1 contained 40-80 pg endotoxin per milligram of protein.
Adding rlL-1 to known quantities of endotoxin did not interfere with the LAL assay. Human rIFN-y was produced in E. coli and purified to >98% purity (26) . IFN-y concentrations were determined in a cytopathic inhibition assay using A549 cells challenged with encephalomyocarditis virus, rlFN-y used in these studies has asp act of 1-2 x 107 U/mg. Ibuprofen formulated for intravenous injection was provided by Upjohn Co., Kalamazoo, MI.
Trypsin Treatment. rTNFc~ (2 mg) was incubated with TPCK-treated trypsin (Cooper Biomedical, Freehold, NJ) at 37°C. Trypsin (20/~g) was added at 0, 12, 24, and 36 b. After 48 h of incubation, soybean trypsin inhibitor (160 ug; Sigma Chemical Co., St. Louis, MO) was added to each sample. Limulus lysate testing of the trypsinized rTNFc~ revealed 1 ng/mg endotoxin.
Pyrogen Testing. New Zealand-derived female rabbits weighing ~2.5-3.0 kg (Pine Acres, Burlington, VT) were trained in restraining devices for 1 wk before pyrogen testing. Core temperature was measured using indwelling rectal thermistors (Yellow Springs Instruments, Yellow Springs, OH) and a Kaye Digistrip Model II recorder (Bedford, MA). Rectal temperatures were measured every minute, as described previously (21) . The murine fever studies used C3H/HeJ mice, individually caged in an ambient temperature of 33-34°C. Body temperatures were measured with thermosensitive radiotelemetry devices (XM-FH; Minimitter Co., Inc., Sunriver, OR) implanted subcutaneously. After 2 h of stabilization, each mouse was injected with 0.1 ml of either PBS or a dilution of rTNF in PBS (six mice per group). Body temperature was measured at 10-min intervals before and after injection by determining the frequency emitted by each telemeter. The signal was detected with a Minimitter RA-1000-TH receiver coupled to a digital frequency counter (Heathkit SM 2420, Benton Harbor, MI) and converted to temperature using a previously determined calibration index. PGE2 Production and Measurements. Rabbit hypothalami were removed, minced, and incubated for 15 min at 37°C. After washing to remove PG induced by tissue trauma, aliquots were incubated for 60 min with various concentrations ofrTNFa or rIL-1 in the presence of clinical grade polymyxin B (25 pg/ml) (Pfizer, Groton, CT) as previously described (21, 28) . The supernatants were frozen at -70°C and later assayed for PGE2 using a specific RIA (Seragen, Boston, MA).
Human Mononuclear Cell Incubations. Blood was obtained from healthy donors, and the mononuclear cells (MNC) were isolated as previously described (29) . Methods for stimulating endogenous pyrogen activity for rabbit pyrogen testing using 5-ml volumes of MEM (Microbiological Associates, Walkersville, MD) have been described in detail (29) . MNCs were also incubated with IFN-'y and rTNFa for 48 h in 1-ml wells with 2.5 × 106 cells/ml. For these experiments, MNCs were suspended in MEM (Gibco, Grand Island, NY) containing 10% FCS (Hyclone, Logan, UT). Supernatants were diluted and assayed for IL-1 activity on thymocytes.
IL-1 Murine Thymocyte Assay. Thymocytes from C3H/HeJ mice (The Jackson Laboratory, Bar Harbor, ME) were removed and used to test IL-1 activity in the supernatants of human MNC using augmentation of [3H]thymidine incorporation in response to suboptimal concentrations (1 #g/ml) of PHA-P (Burroughs Wellcome, Research Triangle, NC) as previously described (9, 30) . Purified human monocyte IL-1 was used as a standard in these assays (9) .
Western Blot Analysis. Methods for western blot analysis were used as previously described (37) . Blots were developed using goat anti-rabbit IgG followed by ~25I-labeled protein A (Amersham Corp., Arlington Heights, IL).
Cytotoxicity Assay. Cytotoxicity of the murine fibroblast L929 line was used to assay rTNFc~ activity (31) .
Results
Pyrogenicity of rTNFa. Rabbits were given an intravenous bolus injection of freshly thawed rTNFa diluted and mixed with 1.0 ml of 0.15 M NaCI containing 250 pg/ml of polymyxin B. As shown in Fig. 1A , rTNFa and rIL-1 at a dose of 1 pg/kg produce febrile responses characteristic of endogenous pyrogens, with monophasic fevers reaching mean peak elevations 48-54 rain after the injections. The injection of 0.1 #g/kg of rTNFa did not induce significant fever (<0.3 °C), whereas 0.1 t~g/kg of rIL-1 induced small but significant fever (>0.3°C; data not shown). The fevers produced by either rTNFa or rlL-1 are unlike those produced by endotoxin in which the monophasic fever reaches peak elevation at ~90 min after the injection (1). In addition, the amount of endotoxin that was detected in either the rTNF~ or rIL-1 was clearly below the minimum pyrogenic threshold for endotoxins in rabbits (3-5 ng/kg) (1) . As shown in Fig. 1 B, the fever induced by rTNFa is blocked by prior treatment with the cyclooxygenase inhibitor and antipyretic, ibuprofen (32) . Higher doses of rTNFa (10 ~g/kg) induce biphasic fevers with the second fever peak occurring after 3.5 h. As shown in Fig. 2 , heating rTNF~ for 30 rain at 70°C reduced the second fever peak without affecting the initial febrile response. However, the pyrogenicity of rTNFa was markedly reduced by trypsin treatment. The cytotoxicity assay of trypsinized rTNFa revealed that the treatment reduced biological activity of the rTNFa by -80% and that heat treatment reduced activity by 50% (data not shown).
Although the concentrations of endotoxin in the rTNFot (see Materials and Methods) were below that which would induce fever in rabbits, we employed the endotoxin-resistant C3H/HeJ mouse for additional pyrogen testing. As shown in Fig. 3 , rTNFa produces fever in these mice at 1 and 10 ug/kg. Significant elevations of body temperature occurred 40 min after intraperitoneal injections.
Rabbits injected daily with endotoxins develop progressive pyrogenic unresponsiveness (pyrogenic tolerance). In an attempt to induce pyrogenic tolerance to rTNFa, injections of rTNFa (10 #g/kg) were given to rabbits on four consecutive days. In general, no demonstrable decreases in febrile responses were observed. Three representative individual rabbit febrile responses are shown in Fig. 4 . Rabbit 2 did show decreasing fever with successive injections of rTNF. However, this rabbit became ill (diarrhea and lethargy) after the second injection and died before the fourth injection. During the course of these studies, 56 rabbits received repeated injections of rTNFa (all intravenous), and 6 rabbits (11%) were found dead in their cages. In contrast, no rabbits receiving repeated injections of rIL-1 died.
To determine the cause of the second fever peak, rabbits injected with rTNFa were bled during the uprise of their second fever peak, and the heparinized plasma was pooled and stored for 24 h at 4°C. This plasma was injected into fresh rabbits, and as shown in Fig. 5 , produced a monophasic fever. The pyrogenicity of the circulating plasma was destroyed by heating at 70°C for 30 rain. The heat lability of the plasma factor is similar to that of rlL-1, as shown in Fig. 1 A. On the other hand, rTNFo~, heated in the same water bath as the rlL-1, retained its ability to induce the first fever peak (see Fig. 2 ). The data from these experiments support the concept that the second fever peak after rTNFa is due to the production of IL-1 in vivo. rTNF~ and rlL-1 Induce Hypothalamic PGE2 In Vitro. The rapid rise in body temperature that characterizes the febrile response to either rTNFa or rlL-1 suggests a direct hypothalamic stimulation, most likely mediated, in part, by an increase in PGE2 synthesis. A single intravenous injection of ibuprofen (10 mg/kg) given immediately before rTNFa blocked the febrile response, as pre- viously shown for IL-1 (32) . Rabbit hypothalamic minces were incubated with rTNFa or rIL-1 for 60 min, and the level of PGE2 was assayed in the supernatant media. As reported previously (12, 21, 28) , one onehundredth of the amount of IL-1 necessary to produce 0.6°C fever in rabbits approximately doubled the PGE2 detected in the supernatant of hypothalamic minces after 60 min. As shown in Fig. 6 , the specific activities of rTNFa and rIL-1 were similar in terms of PGE2 production in three separate experiments.
Production of IL-I In Vitro from Human MNC Incubated with rTNFa.
To elucidate the probable mechanism by which intravenous injection of rTNFa in rabbits induces the production of a circulating endogenous pyrogen (IL-1 or rain F~GURE 7. Mean fevers in rabbits injected with supernatants derived from human MNC stimulated with rTNFa (50 ng/ml). Supernatants from the MNC of two human subjects were pooled; half was heated (70°C for 30 rain) before injection. Rabbits were injected with supernatants derived from 10 n monocytes/kg. The numbers in parentheses indicate the number of rabbits used to assay the supernatants. * 24-h MNC supernatants were generated in 25-ml flasks containing 5 × 106 MNC/ml (5 ml/flask) in the presence of 100 ng/ml rTNFa. For these experiments, MNC were isolated from two human subjects. Rabbits were injected with the supernatant derived from 106 monocytes/kg. * Anti-IL-1 (15) or normal rabbit serum was mixed at 1% (vol/vol) with the MNC supernatants, incubated overnight at 4°C and centrifuged (10,000 g) for 2 min. Number of rabbits used to assay supernatants. TNF), human MNC were stimulated in vitro with various concentrations of rTNFa, and the supernatant media were assayed for endogenous pyrogen activity in rabbits. As shown in Fig. 7 , the supernatant medium from human MNC incubated for 24 h with rTNFa induced a monophasic fever when injected into rabbits. The amount of rTNF~ added to the MNC (50 ng/ml) was below the rabbit pyrogen threshold (see Fig. 1B ). After the incubations, the supernatant media were tested for TNF~r activity using an ELISA, and there was no increased TNFa in the supernatant over the amount that was added exogenously (data not shown). The pyrogenic activity in these supernatants was destroyed by heating at 70°C for 30 min, suggesting that this was likely due to IL-1 and not monocytederived TNF/cacbectin. As shown in Table I , the monophasic fever-inducing activity in the stimulated MNC supernatants was IL-1, since it was neutralized by anti-human monocyte IL-1. This antibody did not recognize human rTNF or naturally-derived cachectin, as determined by western blot analysis (Fig. 8) .
Anti-IL-1 had no effect on rTNF~ in the cytotoxicity assay (data not shown). The dose response of rTNFo~ induction of IL-1 is shown in Fig. 9 . At 4-(70=C, 30 min ) PmxB FIGURE 9. Mean peak fever 4-SEM in rabbits injected with materials indicated under the abscissa. All MNC incubations were in the presence of 12.5 pg/ml polymyxin B. The numbers in parentheses indicate the number of rabbits used to assay the pyrogenic activity in the MNC supernatants.
concentrations of 10-500 ng/ml, rTNF induced IL-1 (as measured by peak fever in rabbits). The amount of r T N F a that induced IL-1 was optimal between 50 and 100 ng/ml, whereas concentrations of 500 ng/ml induced less IL-1 (although not significantly different from 100 ng/ml, p > 0.05). Heating r T N F a for 30 min at 70°C destroyed its ability to induce IL-1 in vitro; this finding confirms the observation that heat-treated rTNF~ does not induce a second fever peak in rabbits (see Fig. 2 ).
As expected, supernatants of human MNC stimulated with rTNFo~ contained IL-1, as measured by augmentation of T cell proliferation in response to PHA (Table II) . The IL-l-inducing property of r T N F a was sensitive to heat and trypsinization. However, the amount of IL-1 detected in the T cell assay was less than that assayed in endotoxin-stimulated MNC supernatants. This may have been due to interference of TNFct in the IL-1 assay, although incubating rlL-1 with rTNF~ in the thymocyte assay resulted in only slight inhibition of the IL-1 activity (data not shown). It is also possible that rTNFc~ stimulated the production of inhibitory substances from the mononuclear cells. Although detection of these IL-l-inhibiting substances in the rabbit pyrogen assay is unlikely, several investigators (33) have shown that stimulated monocytes release substances that inhibit T cell proliferation in this assay. Production of IL-1 from human MNC by rTNF~ was enhanced by coincubation with rlFN-7. As depicted in Fig. 10, rlFN-7 (1 ng/ml) enhanced IL-1 production by rTNFo~ at 0.25 ng/ml. rTNF~ has no intrinsic proliferation-enhancing activity except at high concentrations (500 ng/ml; p < 0.05) (Fig. 11) . This activity may reflect the induction of IL-1 from contaminating murine thymic epithelial cells or macrophages, since it was neutralized with anti-mouse IL-1. In situ production of IL-1 during the T cell assay has been observed with other substances, such as the polypeptide toxin elaborated by certain strains of toxic shock syndrome-associated Staphylococcus aureus (34) .
Discussion
These studies show that rTNFa causes fever because it is intrinsically pyrogenic and is capable of increasing hypothalamic PGE2 synthesis. Following an intravenous injection of 1 #g/kg, rabbits develop monophasic fevers that reach peak elevations after 45-55 rain and then return to baseline levels. The only other well-defined substance of leukocyte origin that produces this rapid increase in core temperature is IL-1. Because it is a product of stimulated leukocytes, TNF/cachectin must now be considered an endogenous pyrogen. In Phase I clinical trials, rTNFt~ injected into humans is pyrogenic (S. Sherwin and S. Saks, unpublished observations). Mice passively immunized with anticachectin antibodies survive a lethal dose of endotoxin but still develop fever (35) . In these mice FIGURE I 1. Comparison of rTNFa and rlL-I on thymocyte proliferation to PHA. Antimouse IL-1 (1:2,000 dilution, vol/vol) was added to some wells with the rTNF~z. Anti-mouse IL-1 was raised in goats to IL-I purified from PS88D cell line (kind gift of Dr. Morris Sheetz, Eli Lilly and Co., Indianapolis, IN). With these thymocytes, concentrations of rTNFa at 500 ng/ml induced significant IL-l-like activity (p < 0.05, Student's t-test.).
it is likely that both cachectin and IL-1 are produced, but IL-1 is not neutralized by the anticachectin antibody. Thus, it is IL-1 that probably mediates the fever in these passively immunized mice. It appears that rTNF~ and rlL-1 have approximately the same specific activities in terms of their ability to induce rapidonset fevers after intravenous injection in mice and rabbits. At present, there are no studies of rlL-1 injected into human subjects, and the sensitivity of humans to IL-1 remains to be studied. Although there is another endogenous pyrogen, IFN-o~ (21, 22) , the amount of IFN-~ required to produce fever in rabbits or mice is 100-fold greater than rlL-1 or rTNF~. However, IFNs have known species specificities which may explain this dose-relationship in nonhuman species.
From clinical and laboratory data, three leukocyte products can now be identified as being endogenous pyrogens, IL-1, IFN-~ and TNF/cachectin. What remains to be established is whether any or one or all three of these substances mediates the febrile response to a particular disease. In patients with infectious diseases in which endotoxin plays a pathogenic role, it is likely that all are produced. Extensive laboratory evidence has established that endotoxin stimulates TNF/cachectin production (36, 37), IL-1 (13), and IFN production (38, 30) . However, it may be that in some viral diseases, i.e., cytomegalic disease and hepatitis B, IFN predominates as the primary endogenous pyrogen, since many components of the acute-phase response are not induced by IFN and are frequently absent in various viral diseases. Likewise, TNF/cachectin may be the mediator of fever in certain parasitic diseases. Considerable clinical and laboratory investigation remain before the role of each or combinations of these endogenous pyrogens can be established in a comprehensive explanation for the pathogenesis of fever.
The recently reported amino acid sequences of human TNF-~ (94), cachectin (23) and IL-1 (16, 40) indicate no obvious sequence homologies. Two forms of I L-1 have been identified (16, 17) , which correspond to the two isoelectric points, pI 7 and 5. These two forms were originally described as endogenous pyrogens in 1974 (18) , but their physical relationship at that time was not clear. At the amino acid level, these two forms share little homology; however, at the carboxyl end of each form, 38% absolute and 78% conserved sequence homology exist (41) , and it seems likely that the active site for the biological properties which the two IL-1 forms share resides in these sequences. Nevertheless, when the shared carboxyl segments are matched with TNF~ or iymphotoxin (TNFI3), no striking sequence homology can be observed. Despite their independent structure, TNF/cachectin and IL-1 both produce fever, stimulate neutrophils (11, 42) , induce synovial cell collagenase production (43), decrease lipoprotein lipase (37, 44) , and are cytotoxic for tumor cells (45, 46) .
Using rTNFo~ in these studies, as has been shown (37) using purified natural cachectin, TNF/cachectin has no IL-1 activity on T cells. This may explain the findings of Damais et al. (47) , who reported that muramyl dipeptide polyalanine/lysine stimulated macrophages to release a pyrogenic substance that is not active on lymphocytes. Induction of TNF/cachectin would explain the activity responsible for the fever-producing property of these supernatants.
At higher doses, rTNFc~ induces a biphasic fever. Using passive transfer of plasma taken during the rise of the second fever peak, a circulating substance produced a monophasic fever when injected into new rabbits. This circulating pyrogenic substance is probably not residual rTNFa, since the pharmacokinetics of rTNF and natural cachectin indicate that >95% of the injected material is cleared from the circulation in 3 h (48) . The experiments presented in the present study suggest that the second fever peak represents IL-1 induced by rTNFa in vivo. To support this observation, rTNFa was shown to induce IL-1 production from human MNC in vitro. Although the rabbit pyrogen assay was used to test the IL-1 content of the stimulated MNC supernatants, it can no longer be assumed that brisk monophasic fevers in rabbits is a valid assay for the presence of IL-1. As a result of these studies, it is now clear that either rTNFa or rIL-1 induce indistinguishable fevers within 60 rain of intravenous injection. Thus, the endogenous pyrogen assay in rabbits requires conditions for specificity. At present, these seem to be (a) the ability of heating at 70°C for 30 rain to destroy the fever-inducing property of IL-1 but not rTNFa, and (b) the use of an anti-human IL-1, which neutralizes IL-l's pyrogenic property but does not recognize TNF/cachectin. Using these two conditions, it seems clear that the pyrogenic moiety in rTNFa-stimulated MNC supernatants is indeed IL-1 and not more TNF. The use of the T cell assay was also important in demonstrating that rTNFa induces IL-1, since TNF/cachectin is not active on T cells. The biphasic fever curve seen after administration of rTNFa suggests that rTNFa has two separate effects: the induction of PGE2 and the induction of ILl. The initial fever peak (PGEz-mediated) has a much lower threshold (<1 /~g/ kg) than the secondary fever peak (IL-l-mediated) in which the dose of rTNFa must be between 5 and 10 #g/kg in order to evoke the delayed fever (Fig. 1 B) . In addition, the primary response is not abolished by prior heating of rTNFa at 70°C for 30 min, whereas the secondary response is completely eliminated by this treatment. However, based on the cytotoxicity assay, the heat-treated rTNFa still retains 20% of its original activity. The loss of the secondary fever response probably reflects this decrease in potency. Currently, we have no evidence for the presence of two distinct receptors mediating these two effects for rTNFa, but is seems unlikely that a single receptor would have two different thresholds, each mediating a separate response such as the production of PGE2 and IL-1.
Previous work (49) has shown that colony-stimulating factors induce IL-1 production. In addition, there are partially characterized lymphokines, secreted in response to mitogen or antigen, which induce monocytes to produce IL-1 (50) (51) (52) . The present studies raise the question of whether one of these lymphokines is lymphotoxin (TNF3), since this molecule is closely related to TNF/cachectin (24) .
These studies shed light on the long-unexplained finding (53-55) that during the second fever peak in rabbits given intravenous injections of influenza virus, the plasma contained a substance which, when injected into new rabbits, induced another biphasic fever. It had been established that the pyrogenic moiety circulating during the second fever peak was not due to remaining virus but rather to a host product. It was also shown that fever-inducing factor(s) circulating during the plasma-induced second fever peak contained characteristic endogenous pyrogen (54) , and it now seems certain that this pyrogen was IL-1. However, using large amounts of purified rabbit IL-1, only monophasic fevers have been observed (P . Murphy, personal communication) . Thus, the concept that IL-1 induces more IL-1 in vivo has been difficult to substantiate even using in vitro production methods (55) . Considering the data of the present report, it seems possible that the circulating factor detected by passive transfer of plasma from febrile rabbits may have been to due to TNF/cachectin rather than IL-1.
Summary
Recombinant human tumor necrosis factor (rTNFa) injected intravenously into rabbits produces a rapid-onset, monophasic fever indistinguishable from the fever produced by rIL-1. On a weight basis (1 t~g/kg) rTNFe and rIL-1 produce the same amount of fever and induce comparable levels of PGE~ in rabbit hypothalamic cells in vitro; like IL-1, TNF fever is blocked by drugs that inhibit cyclooxygenase. At higher doses (10 ug/kg) rTNFa produces biphasic fevers. The first fever reaches peak elevation 45-55 min after bolus injection and likely represents a direct action on the thermoregulatory center. During the second fever peak (3 h later), a circulating endogenous pyrogen can be shown present using passive transfer of plasma into fresh rabbits. This likely represents the in vivo induction of IL-1. In vitro, rTNFa induces the release of IL-1 activity from human mononuclear cells with maximal production observed at 50-100 ng/ml of rTNFa. In addition, rTNFo~ and rIFN-3, have a synergistic effect on IL-1 production. The biological activity of rTNF~ could be distinguished from IL-1 in three ways: (a) the monophasic pyrogenic activity of rIL-1 was destroyed at 70°C, whereas rTNFo remained active; (b) anti-IL-1 neutralized IL-1 but did recognize rTNFa or natural cachectin nor neutralize its cytotoxic effect; and (c) unlike IL-1, rTNFa was not active in the mitogen-stimulated T cell proliferation assay. The possibility that endotoxin was responsible for rTNFa fever and/or the induction of IL-1 was ruled-out in several studies: (a) rTNFa produced fever in the endotoxin-resistant C3H/HeJ mice; (b) the IL-l-inducing property of rTNFa was destroyed either by heat (70 ° C) or trypsinization, and was unaffected by polymyxin B; (c) pyrogenic tolerance to daily injections of rTNFe did not occur; (d) levels of endotoxin, as determined in the Limulus amebocyte lysate, were below the minimum rabbit pyrogen dose; and (e) these levels of endotoxin were confirmed by gas chromatography/mass spectrometry analysis for the presence of t3-hydroxymyristic acid. Although rTNFo~ is not active in T cell proliferation assays, it may mimic IL-1 in a T cell assay, since high concentrations of rTNF~ induced IL-1 from epithelial or macrophagic cells in the thymocyte preparations. These studies show that TNF (cachectin) is another endogenous pyrogen which, like IL-1 and IFN-~, directly stimulate hypothalamic PGE~ synthesis. In addition, rTNFe is an endogenous inducer of IL-1. Together, these results support the concept that the febrile response to infection is a fundamental event in host defense and the induction of fever by endogenously produced molecules is not imparted to a single substance.
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